Literature DB >> 16689116

Advance health planning and treatment preferences among recipients of implantable cardioverter defibrillators: an exploratory study.

Jeffrey T Berger1, Matthew Gorski, Todd Cohen.   

Abstract

Mesh：

Year:  2006        PMID： 16689116

Source DB:  PubMed          Journal:  J Clin Ethics        ISSN： 1046-7890


× No keyword cloud information.
  9 in total

Review 1.  Informed consent in cardiac resynchronization therapy: what should be said?

Authors:  Daniel B Kramer; Dan W Brock; Usha B Tedrow
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-09

2.  The use of advance directives among patients with implantable cardioverter defibrillators.

Authors:  Tanya H Tajouri; Abigale L Ottenberg; David L Hayes; Paul S Mueller
Journal:  Pacing Clin Electrophysiol       Date:  2012-03-20       Impact factor: 1.976

3.  Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.

Authors:  Suraj Kapa; Paul S Mueller; David L Hayes; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2010-09-15       Impact factor: 7.616

4.  The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.

Authors:  Ruth England; Tim England; John Coggon
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

5.  The prevalence and contents of advance directives in patients with pacemakers.

Authors:  Dario Pasalic; Tanya H Tajouri; Abigale L Ottenberg; Paul S Mueller
Journal:  Pacing Clin Electrophysiol       Date:  2013-11-11       Impact factor: 1.976

Review 6.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883

7.  Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis.

Authors:  Valentina Gonzalez-Jaramillo; Piotr Sobanski; Jose A Calvache; Luisa F Arenas-Ochoa; Oscar H Franco; Lukas Hunziker; Steffen Eychmüller; Maud Maessen
Journal:  Palliat Med       Date:  2020-06-26       Impact factor: 4.762

8.  Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.

Authors:  Rik Stoevelaar; Arianne Brinkman-Stoppelenburg; Anne Geert van Driel; Rozemarijn L van Bruchem-Visser; Dominic Amj Theuns; Rohit E Bhagwandien; Agnes Van der Heide; Judith Ac Rietjens
Journal:  Heart       Date:  2019-09-19       Impact factor: 5.994

9.  Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks?

Authors:  Ingela Thylén; Debra K Moser; Misook L Chung; Jennifer Miller; Christina Fluur; Anna Strömberg
Journal:  Int J Cardiol Heart Vessel       Date:  2013-11-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.